Results 121 to 130 of about 57,105 (142)

Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease. [PDF]

open access: yesJ Neurol
Toffoli M   +18 more
europepmc   +1 more source

Mucoactive Agents in Muco-Obstructive Lung Diseases: A Critical Reappraisal of Pharmacological Effects and Clinical Outcomes. [PDF]

open access: yesPharmaceuticals (Basel)
Larobina D   +15 more
europepmc   +1 more source

Meta-analysis of the adjuvant treatment of COPD with Erchen Decoction. [PDF]

open access: yesMedicine (Baltimore)
Gao X, Lv X, Dong W, Zhang L, Zuo J.
europepmc   +1 more source

Modest improvement of metabolic and behavioral deficits with long-term ambroxol treatment in a Pink1<sup>-/-</sup>SNCA<sup>A53T</sup> double mutant mouse model of Parkinson's disease. [PDF]

open access: yesActa Pharmacol Sin
Franck L   +10 more
europepmc   +1 more source

Low Energy Vibrations and Crystalline Structure of Ambroxol Hydrochloride by THz Spectroscopy and DFT Calculations

open access: yesChemistrySelect, 2023
Solid‐state density functional theory was utilized to determine the crystalline structure and analyze terahertz spectra of Ambroxol hydrochloride, a widely used drug. The vibration mode for each spectral feature has been described in terms of complex inter‐ and intramolecular movements.
Jan Rohlicek   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Home - About - Disclaimer - Privacy